BGM
Qilian International Holding Group Limited
NASDAQ: BGM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.29
-2.33% today
Updated 2026-04-30
Market cap
$66.81M
P/E ratio
—
P/S ratio
0.24x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$0 – $17
Volume
0.3M
Qilian International Holding Group Limited (BGM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-15.60%
ROE
-16.50%
ROA
-3.84%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $22.54M | $1.41M | 15.01% | 5.02% | 6.28% |
| 2018 | $50.37M | $5.17M | 16.15% | 11.86% | 10.26% |
| 2019 | $46.10M | $5.33M | 21.00% | 13.40% | 11.57% |
| 2020 | $50.03M | $5.06M | 15.07% | 9.62% | 10.12% |
| 2021 | $57.10M | $3.15M | 9.87% | 4.18% | 5.52% |
| 2022 | $64.86M | $1.08M | 9.60% | 3.24% | 1.66% |
| 2023 | $46.47M | $-7.78M | 3.77% | -5.62% | -16.74% |
| 2024 | $25.10M | $-1.44M | 16.39% | -2.25% | -5.75% |